IL110175A - Tetrahydro pyrazolo (3,4-c)pyridine and the corresponding 7-one derivatives and pharmaceutical compositions containing them - Google Patents

Tetrahydro pyrazolo (3,4-c)pyridine and the corresponding 7-one derivatives and pharmaceutical compositions containing them

Info

Publication number
IL110175A
IL110175A IL11017594A IL11017594A IL110175A IL 110175 A IL110175 A IL 110175A IL 11017594 A IL11017594 A IL 11017594A IL 11017594 A IL11017594 A IL 11017594A IL 110175 A IL110175 A IL 110175A
Authority
IL
Israel
Prior art keywords
pyridine
derivatives
pharmaceutical compositions
compositions containing
tetrahydro pyrazolo
Prior art date
Application number
IL11017594A
Other languages
English (en)
Other versions
IL110175A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL110175A0 publication Critical patent/IL110175A0/xx
Publication of IL110175A publication Critical patent/IL110175A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL11017594A 1993-07-06 1994-06-30 Tetrahydro pyrazolo (3,4-c)pyridine and the corresponding 7-one derivatives and pharmaceutical compositions containing them IL110175A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8829293A 1993-07-06 1993-07-06

Publications (2)

Publication Number Publication Date
IL110175A0 IL110175A0 (en) 1994-10-07
IL110175A true IL110175A (en) 2000-01-31

Family

ID=22210524

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11017594A IL110175A (en) 1993-07-06 1994-06-30 Tetrahydro pyrazolo (3,4-c)pyridine and the corresponding 7-one derivatives and pharmaceutical compositions containing them

Country Status (20)

Country Link
EP (1) EP0707585A1 (it)
JP (1) JP2944048B2 (it)
KR (1) KR100228949B1 (it)
CN (1) CN1048015C (it)
AU (1) AU695301B2 (it)
BR (1) BR9406946A (it)
CA (1) CA2166721C (it)
CZ (1) CZ3696A3 (it)
EG (1) EG20513A (it)
FI (1) FI943208A (it)
HU (1) HUT74170A (it)
IL (1) IL110175A (it)
MX (1) MX9405132A (it)
NO (1) NO305029B1 (it)
NZ (1) NZ266525A (it)
PL (1) PL312426A1 (it)
RU (1) RU2131876C1 (it)
TW (1) TW316904B (it)
WO (1) WO1995001980A1 (it)
ZA (1) ZA944844B (it)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970707124A (ko) * 1994-10-20 1997-12-01 스피겔 알렌 제이 비사이클릭 테트라하이드로 피라졸로피리딘 및 약제로서 이의 용도(bicyclic tetrahydro pyrazolopyridines and their use as medicaments)
ES2172583T3 (es) * 1995-06-06 2002-10-01 Pfizer 5,6-dihidro-9h-pirazol(3,4-c)-1,2,4-triazol(4,3-alfa)piridinas triciclicas.
AP932A (en) * 1996-08-26 2001-02-02 Pfizer Tricyclic 5,6-dihydro-9H-pyrazolo (3,4c)-1,2,4,-triazolo (4,3-a) pyridines.
PL332187A1 (en) * 1996-09-04 1999-08-30 Pfizer Substitution derivatives of indazole and their application as inhibitors of phosphodiesterase (pde) of iv type and tumor necrosis factor (tnf)
US6858616B2 (en) 1998-12-23 2005-02-22 Bristol-Myers Squibb Pharma Company Nitrogen containing heterobicycles as factor Xa inhibitors
PT1140941E (pt) * 1998-12-23 2005-02-28 Bristol Myers Squibb Pharma Co Heterociclicos que contem azoto como inibidores do factor xa
US6326495B2 (en) 1999-04-30 2001-12-04 Pfizer Inc. Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
NZ517166A (en) 1999-08-21 2004-01-30 Altana Pharma Ag Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonists
TWI243055B (en) * 2000-04-13 2005-11-11 Nippon Zoki Pharmaceutical Co Pharmaceutical composition for use in treatment of dermatitis
DK1320531T3 (da) * 2000-08-10 2011-01-03 Pfizer Italia Srl Bicyclo-pyrazoler, der er aktive som kinase inhibitorer, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger, der indeholder disse
US6960595B2 (en) * 2001-03-23 2005-11-01 Bristol-Myers Squibb Pharma Company 5-6 to 5-7 Heterobicycles as factor Xa inhibitors
EP1379245A4 (en) 2001-04-18 2006-07-26 Bristol Myers Squibb Co 1, 4, 5, 6-TETRAHYDROPYRAZOLO- 3, 4-C-PYRIDINE-7-ONE AS FACTOR XA HEMMER
US6706730B2 (en) 2001-04-18 2004-03-16 Bristol-Myers Squibb Pharma Company 1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones as factor Xa inhibitors
JP4196678B2 (ja) 2001-04-26 2008-12-17 味の素株式会社 複素環化合物
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DK1611131T3 (da) 2003-02-27 2011-01-17 Palau Pharma Sa Pyrazolopyridin-derivater
US7135469B2 (en) * 2003-03-18 2006-11-14 Bristol Myers Squibb, Co. Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
AU2004226353A1 (en) 2003-04-01 2004-10-14 Laboratoires Serono Sa Inhibitors of phosphodiesterases in infertility
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
DE102005031580A1 (de) * 2005-07-06 2007-01-11 Aicuris Gmbh & Co. Kg Substituierte Sulfolanylpyrazole und ihre Verwendung
PE20081889A1 (es) * 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8034782B2 (en) 2008-07-16 2011-10-11 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2930674A1 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2828346C (en) 2011-03-01 2021-01-26 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
CN105979959B (zh) 2013-08-09 2021-11-30 阿德利克斯公司 用于抑制磷酸盐转运的化合物和方法
CN110357888A (zh) * 2018-04-09 2019-10-22 南京药捷安康生物科技有限公司 杂环磷酸二酯酶抑制剂及其用途
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340269A (en) * 1964-09-08 1967-09-05 Ciba Geigy Corp 1-substituted 4-acyl-2, 3-dioxo-piperidine
US3365459A (en) * 1964-09-08 1968-01-23 Ciba Geigy Corp Certain tetrahydro pyrazolo-pyridine and pyrazolo-piperidine derivatives
FR1463883A (fr) * 1964-09-08 1966-07-22 Ciba Geigy Procédé de préparation de triaza-composés bicycliques
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines

Also Published As

Publication number Publication date
NO960056L (no) 1996-01-05
HU9503934D0 (en) 1996-03-28
ZA944844B (en) 1996-01-05
AU6805794A (en) 1995-02-06
RU2131876C1 (ru) 1999-06-20
NO960056D0 (no) 1996-01-05
IL110175A0 (en) 1994-10-07
WO1995001980A1 (en) 1995-01-19
CN1048015C (zh) 2000-01-05
TW316904B (it) 1997-10-01
HUT74170A (en) 1996-11-28
JP2944048B2 (ja) 1999-08-30
EG20513A (en) 1999-06-30
JPH08507084A (ja) 1996-07-30
KR100228949B1 (ko) 1999-11-01
NO305029B1 (no) 1999-03-22
NZ266525A (en) 1997-10-24
EP0707585A1 (en) 1996-04-24
CA2166721C (en) 1999-07-27
FI943208A0 (fi) 1994-07-05
KR960703852A (ko) 1996-08-31
CZ3696A3 (en) 1997-06-11
AU695301B2 (en) 1998-08-13
CA2166721A1 (en) 1995-01-19
CN1129940A (zh) 1996-08-28
FI943208A (fi) 1995-01-07
MX9405132A (es) 1995-01-31
BR9406946A (pt) 1996-08-06
PL312426A1 (en) 1996-04-29

Similar Documents

Publication Publication Date Title
IL110175A (en) Tetrahydro pyrazolo (3,4-c)pyridine and the corresponding 7-one derivatives and pharmaceutical compositions containing them
IL111422A0 (en) 10, 11 beta-c2-bridged steroids and pharmaceutical compositions containing the same
IL108372A0 (en) 2,6-Diaminopurine derivatives, their preparation and pharmaceutical compositions containing them
HUT74464A (en) 1n-alkyl-n-arylpyrimidinamines and derivatives thereof, and pharmaceutical compositions containing them
ZA931637B (en) Pyrrolobenzodiazepine derivatives, their preparation and compositions containing them
IL111526A0 (en) 7H-imidazo (1,2-a) pyrazin-8-one derivatives and their preparation and use
IL106141A0 (en) Thiazolylvinylphenyl derivatives,their manufacture and pharmaceutical compositions containing them
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL110988A0 (en) 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same
IL108636A0 (en) Polysubstitued 2-amino-thiazole derivatives, their preparation and pharmaceutical compositions containing them
NZ241943A (en) PYRROLO [2,3-b] PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS
NZ235270A (en) Diazepinone derivatives and pharmaceutical compositions
IL108703A0 (en) Substituted azolone derivatives, their preparation and pharmaceutical compositions containing them
IL105348A0 (en) Azabicyclo derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HU9600427D0 (en) Benzazepine derivative, pharmaceutical composition containing the same, and intermediate for the same
IL106761A0 (en) 4,5-dihydro-4-oxo-pyrrolo(1,2-a)quinoxalinones and corresponding aza analogs,their preparation and pharmaceutical compositions containing them
IL93136A0 (en) Tetrahydroimidazo(1,4)benzodiazepin-2-thione derivatives,their preparation and pharmaceutical compositions containing them
IL110809A0 (en) 1,5-diphenyl-3-pyrazolylalkyl-n-hydroxydithiocarbamates and pharmaceutical compositions containing them
ZA945597B (en) Methyiguanidine derivatives process for their preparation and the compositions containing them
ZA941088B (en) Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them
NZ224032A (en) Imidazo(1,2-a)pyridine derivatives and pharmaceutical compositions
NZ232013A (en) Substituted pyrido(2,3-d)pyrimidines and pharmaceutical compositions
NZ239547A (en) Hydrogenated indolo(1,7-bc)(2,6)naphthyridine derivatives and pharmaceutical compositions
IL105977A0 (en) Benzodiazepines,their preparation and pharmaceutical compositions containing them
AU5220893A (en) Substituted N-hydroxycinnamamides, processes for their preparation, compositions containing them, and their use

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void
FF Patent granted